Before booking fat freezing during GLP-1 treatment, include delayed complications in the consultation.
Ask what the risk number counts
A 2025 systematic review included 28 studies and 13,078 patients, identifying 29 PAH cases. Its pooled estimate was 0.22%, about 1 in 455 patients, with a 95% confidence interval of 0.10% to 0.47%. This is a patient estimate, not a rate per treatment cycle. [2]
Evidence certainty was low. Only four studies reported at least 16 weeks of follow-up, and data were insufficient for device-based meta-analysis. These findings cannot supply a personal or GLP-1-specific risk estimate. Ask whether a clinic's quoted rate counts people or treatment cycles and how long patients were followed. [2]
Agree on follow-up before paying
Ask who assesses a new firm bulge months later, how to arrange that visit and what further care could cost. FDA advises discussing personal risks and reading device information. Non-invasive contouring does not treat obesity or produce weight loss. [1]
For a different appearance concern, read our cellulite consultation guide.
Printed book
How to Keep Your Face on GLP-1
$12.95 + free shipping
Order Now30 day money back guarantee
This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.
Read next
Body & preparationBody Shape on GLP-1: Plan for Muscle, Food and Strength→Body & preparationBreast Changes After GLP-1 Weight Loss: Ask About a Lift→Sources
- Non-Invasive Body Contouring TechnologiesUS Food and Drug Administration↩ Back to text
- Incidence of Paradoxical Adipose Hyperplasia After Cryolipolysis: A Systematic Review and Meta-Analysis, 2025Mah and colleagues, Aesthetic Surgery Journal Open Forum; original review abstract↩ Back to text

